Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006682 · ClinicalTrials.gov registry record · Phase 2
Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer
A Phase 2 study, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00006682 is a Phase 2 study that has completed, run by Medstar Health Research Institute.
The verdict
NCT00006682, a Phase 2 study, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of vinorelbine combined with docetaxel in treating women who have metastatic breast cancer.
Interventions
- DRUG docetaxel
- DRUG vinorelbine ditartrate
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-02 |
| Est. Completion | 2002-01-22 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006682
The ClinicalTrials.gov registry entry for NCT00006682 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which docetaxel is the first listed.
NCT00006682 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006682 about?
NCT00006682 is a clinical study titled "Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of vinorelbine combined with docetaxel in treating women who have metast...
What is the current status of trial NCT00006682?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-02. Estimated completion is 2002-01-22.
What interventions are being tested in trial NCT00006682?
The interventions under investigation include: docetaxel (DRUG), vinorelbine ditartrate (DRUG).
Who is sponsoring clinical trial NCT00006682?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.